Statera Biopharma, Inc. Quarterly Operating Margin in % from Q4 2019 to Q3 2022

Taxonomy & unit
ratio: %
Description
The operating margin measures the profit a company makes on a dollar of sales after accounting for the direct costs involved in earning those revenues.
Summary
Statera Biopharma, Inc. quarterly/annual Operating Margin history and growth rate from Q4 2019 to Q3 2022.
  • Statera Biopharma, Inc. Operating Margin for the quarter ending September 30, 2022 was -2.39K %, a 98.3% increase year-over-year.
  • Statera Biopharma, Inc. annual Operating Margin for 2011 was -286 %, a 308% decline from 2010.
Operating Margin, Quarterly (%)
Operating Margin, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q3 2022 -2.39K +140K +98.3% Jul 1, 2022 Sep 30, 2022
Q2 2022 -2.96K -12.5K -131% Apr 1, 2022 Jun 30, 2022
Q1 2022 -4.01K -13.8K -141% Jan 1, 2022 Mar 31, 2022
Q4 2021 -6.61K Oct 1, 2021 Dec 31, 2021
Q3 2021 -142K -141K -11055% Jul 1, 2021 Sep 30, 2021
Q2 2021 9.57K +9.78K Apr 1, 2021 Jun 30, 2021
Q1 2021 9.77K +9.96K Jan 1, 2021 Mar 31, 2021
Q3 2020 -1.27K Jul 1, 2020 Sep 30, 2020
Q2 2020 -214 Apr 1, 2020 Jun 30, 2020
Q1 2020 -188 Jan 1, 2020 Mar 31, 2020
Q4 2019 -212 Oct 1, 2019 Dec 31, 2019
* An asterisk sign (*) next to the value indicates that the value is likely invalid.